SEC Form 4 · accession 0001209191-19-002077
Flexion Therapeutics Inc · FLXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Arkowitz
Officer — Chief Financial Officer
Period of report
Dec 20, 2018
Accepted (ET)
Jan 4, 2019 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419600
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 20, 2018 | J | 922 | $10.48 | A | 49,172 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4 is being filed voluntarily to report the acquisition of 922 shares by the Reporting Person on December 20, 2018 pursuant to the Issuer's Employee Stock Purchase Plan.